CP and liver cancer: Moreover, high expression of CP in tumor cells, such as lung cancer (Chang et al., 2022), liver cancer (Shang et al., 2020), melanoma (Liu et al., 2022a), and breast cancer (Chen et al., 2021), can inhibit ferroptosis, thus reduces tumor cell death and promotes tumor progression.